Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
Public ClinicalTrials.gov record NCT01239797. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Relapsed or Refractory Multiple Myeloma (MM)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to determine whether the addition of Elotuzumab to Lenalidomide/low-dose Dexamethasone will increase the progression free survival (PFS).
Study identification
- NCT ID
- NCT01239797
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 646 participants
Conditions and interventions
Conditions
Interventions
- Lenalidomide Drug
- Dexamethasone Drug
- Dexamethasone (Oral) Drug
- Dexamethasone (IV) Drug
- Elotuzumab (BMS-901608; HuLuc63) Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 20, 2011 (Actual)
- Primary completion
- Sep 2, 2014 (Actual)
- Completion
- Apr 21, 2021 (Actual)
- Last update posted
- Jun 1, 2022
2011 – 2021
United States locations
- U.S. sites
- 63
- U.S. states
- 25
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northwest Alabama Cancer Center, Pc | Muscle Shoals | Alabama | 35661 | — |
| Acrc/Arizona Clinical Research Center, Inc. | Tucson | Arizona | 85715 | — |
| Local Institution | Berkeley | California | 94704 | — |
| Local Institution | Burbank | California | 91505 | — |
| Compassionate Cancer Res Grp | Corona | California | 92879 | — |
| Local Institution | Corona | California | 92879 | — |
| San Diego Pacific Oncology& Hematology Associates, Inc | Encinitas | California | 92024 | — |
| Local Institution | Greenbrae | California | 94904 | — |
| Ucla-Division Of Hematology/Oncology | Los Angeles | California | 90095 | — |
| Medical Oncology Care Associates | Orange | California | 92868 | — |
| Sharp Clinical Oncology Research | San Diego | California | 92123 | — |
| Local Institution | Vallejo | California | 94589 | — |
| Local Institution | Boca Raton | Florida | 33486 | — |
| Cancer Care Centers Of Florida | Brooksville | Florida | 34613 | — |
| Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| Local Institution | New Port Richey | Florida | 34652 | — |
| Cancer Institute Of Florida | Orlando | Florida | 32804 | — |
| Local Institution | Titusville | Florida | 32796 | — |
| Florida Cancer Specialists | West Palm Beach | Florida | 33401 | — |
| Winship Cancer Institute. | Atlanta | Georgia | 30322 | — |
| Georgia Health Science University | Augusta | Georgia | 30912 | — |
| Orchard Healthcare Research Inc. | Skokie | Illinois | 60077 | — |
| Local Institution | Indianapolis | Indiana | 46260 | — |
| Local Institution | Mishawaka | Indiana | 46545 | — |
| Local Institution | Iowa City | Iowa | 52242 | — |
| Local Institution | Lexington | Kentucky | 40503 | — |
| Local Institution | Louisville | Kentucky | 40207 | — |
| Pikeville Medical Center | Pikeville | Kentucky | 41501 | — |
| Cancer Center Of Acadiana At Lafayette General | Lafayette | Louisiana | 70503 | — |
| Local Institution | Shreveport | Louisiana | 71101 | — |
| Local Institution | Shreveport | Louisiana | 71103 | — |
| Willis Knighton Cancer Center | Shreveport | Louisiana | 71103 | — |
| Dana Farber Cancer Inst | Boston | Massachusetts | 02215 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Capitol Comprehensive Cancer Care Center | Jefferson City | Missouri | 65101 | — |
| Local Institution | Springfield | Missouri | 65807 | — |
| Washington University School Of Medicine | St Louis | Missouri | 63110 | — |
| Local Institution | Las Vegas | Nevada | 89106 | — |
| NYU Clinical Cancer Center | New York | New York | 10016 | — |
| Local Institution | New York | New York | 10019 | — |
| Weill Cornell Medical College | New York | New York | 10065 | — |
| Local Institution | Stony Brook | New York | 11794-8151 | — |
| Levine Cancer Institute | Charlotte | North Carolina | 28204 | — |
| Gaston Hematology & Oncology | Gastonia | North Carolina | 28054 | — |
| Local Institution | Bismarck | North Dakota | 58501 | — |
| University Of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | — |
| Local Institution | Tulsa | Oklahoma | 74136 | — |
| Local Institution | Bethlehem | Pennsylvania | 18015 | — |
| Western Pennsylvania Hospital | Pittsburgh | Pennsylvania | 15224 | — |
| Local Institution | Charleston | South Carolina | 29414 | — |
| Local Institution | Greenville | South Carolina | 29615 | — |
| Local Institution | Knoxville | Tennessee | 37909 | — |
| The West Clinic | Memphis | Tennessee | 38120 | — |
| Cancer Specialists Of South Texas, Pa | Corpus Christi | Texas | 78412 | — |
| Ut Southwestern Medical Center | Dallas | Texas | 75390-8565 | — |
| University Of Texas Md Anderson Cancer Ctr | Houston | Texas | 77030 | — |
| Northwest Cancer Center | Houston | Texas | 77090 | — |
| Hematology-Oncology Associates Of Fredricksburg, Inc | Fredericksburg | Virginia | 22408 | — |
| Va Puget Sound Health Care System | Seattle | Washington | 98108 | — |
| Gundersen Clinic, Ltd | La Crosse | Wisconsin | 54601 | — |
| University Of Wisconsin Hospital And Clinics | Madison | Wisconsin | 53792 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 153 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01239797, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 1, 2022 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01239797 live on ClinicalTrials.gov.